Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first‐line treatment for advanced EGFR‐mutant non‐small cell lung cancer

Zhonghan Zhang; Yang Zhang; Fan Luo; Yuxiang Ma; Wenfeng Fang; Jing Zhan; Su Li; Yunpeng Yang; Yuanyuan Zhao; Shaodong Hong; Ting Zhou; Yaxiong Zhang; Shen Zhao; Yan Huang; Hongyun Zhao; Li Zhang

doi:10.1002/ctm2.33

Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first‐line treatment for advanced EGFR‐mutant non‐small cell lung cancer

Clinical and Translational Medicine ◽

10.1002/ctm2.33 ◽

2020 ◽

Vol 10 (2) ◽

Author(s):

Zhonghan Zhang ◽

Yang Zhang ◽

Fan Luo ◽

Yuxiang Ma ◽

Wenfeng Fang ◽

...

Keyword(s):

Lung Cancer ◽

Pilot Study ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Dual Blockade ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

Phase I Study of Apatinib in Combination with Gefitinib As First-Line Treatment in Patients with EGFR-Mutant Advanced Non-Squamous Non-Small Cell Lung Cancer

SSRN Electronic Journal ◽

10.2139/ssrn.3454715 ◽

2019 ◽

Author(s):

Zhonghan Zhang ◽

Yang Zhang ◽

Fan Luo ◽

Yuxiang Ma ◽

Wenfeng Fang ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Phase I Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

Osimertinib as first-line treatment of EGFR mutant advanced non-small-cell lung cancer

Translational Lung Cancer Research ◽

10.21037/tlcr.2017.10.10 ◽

2017 ◽

Vol 6 (S1) ◽

pp. S62-S66 ◽

Cited By ~ 4

Author(s):

Chong-Kin Liam

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

First-line treatment of EGFR-mutant non-small-cell lung cancer: the role of erlotinib and other tyrosine kinase inhibitors

Biologics: Targets and Therapy ◽

10.2147/btt.s26558 ◽

2012 ◽

pp. 337 ◽

Cited By ~ 4

Author(s):

Joel Neal ◽

Kim-Son H. Nguyen

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Kinase Inhibitors ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

Apatinib plus gefitinib as first-line treatment in advanced EGFR-mutant non-small cell lung cancer: the phase III ACTIVE study (CTONG1706)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.05.006 ◽

2021 ◽

Author(s):

Hongyun Zhao ◽

Wenxiu Yao ◽

Xuhong Min ◽

Kangsheng Gu ◽

Guohua Yu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

Gefitinib (G) and Pemetrexed (Pem) as a First Line Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase II Study

Annals of Oncology ◽

10.1016/s0923-7534(20)33852-7 ◽

2012 ◽

Vol 23 ◽

pp. ix412-ix413 ◽

Cited By ~ 1

Author(s):

N. Yoshimura ◽

K. Matsuura ◽

S. Mitsuoka ◽

K. Asai ◽

Y. Tochino ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

First-Line Treatment in EGFR Mutant Non-Small Cell Lung Cancer: Is There a Best Option?

Frontiers in Oncology ◽

10.3389/fonc.2018.00094 ◽

2018 ◽

Vol 8 ◽

Cited By ~ 11

Author(s):

Ajaz Bulbul ◽

Hatim Husain

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706)

Cancer Communications ◽

10.1186/s40880-019-0414-4 ◽

2019 ◽

Vol 39 (1) ◽

Cited By ~ 3

Author(s):

Zhonghan Zhang ◽

Fan Luo ◽

Yang Zhang ◽

Yuxiang Ma ◽

Shaodong Hong ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Study Protocol ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Egfr Mutant ◽

First Line Treatment

Download Full-text

Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride

Case Medical Research ◽

10.31525/ct1-nct03890055 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Clinical Study ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text

Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC)

Case Medical Research ◽

10.31525/ct1-nct04009317 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Anaplastic Lymphoma Kinase ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Anaplastic Lymphoma ◽

Alk Positive ◽

First Line Treatment

Download Full-text

Real-world outcomes for patients with metastatic non-small cell lung cancer according to first-line treatment

Revue d Épidémiologie et de Santé Publique ◽

10.1016/j.respe.2021.04.057 ◽

2021 ◽

Vol 69 ◽

pp. S36

Author(s):

Y. Belaroussi ◽

S. Cousin ◽

M. Carton ◽

M. Lebitasy ◽

L. Laborde ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

First Line Treatment

Download Full-text